Oender, F. O. Et Al. 2008. HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS. 33rd European-Society-for-Medical-Oncology Congress , (Stockholm, Sweden), 150-151.

Oender, F. O., Utkan, G., Arslan, U. Y., Ulas, A., Tuerker, I., Tokluoglu, S., ... Durnali, A. G.(2008). HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS . 33rd European-Society-for-Medical-Oncology Congress (pp.150-151). Stockholm, Sweden

Oender, Fatih Et Al. "HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS," 33rd European-Society-for-Medical-Oncology Congress, Stockholm, Sweden, 2008

Oender, Fatih O. Et Al. "HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS." 33rd European-Society-for-Medical-Oncology Congress , Stockholm, Sweden, pp.150-151, 2008

Oender, F. O. Et Al. (2008) . "HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS." 33rd European-Society-for-Medical-Oncology Congress , Stockholm, Sweden, pp.150-151.

@conferencepaper{conferencepaper, author={Fatih Oğuz ÖNDER Et Al. }, title={HIGH RATE OF NEUTROPENIA IN PATIENTS TREATED WITH FOLFIRI-BEVACIZUMAB MAY COMPROMISE DOSE INTENSITY OF TREATMENT IN COLORECTAL CANCER PATIENTS WITH LIVER-ONLY METASTASIS}, congress name={33rd European-Society-for-Medical-Oncology Congress}, city={Stockholm}, country={Sweden}, year={2008}, pages={150-151} }